Aesthetic Medical Devices Market is Expected to Hit Worth of US$ 14 Bn in 2022 and is Estimated to Cross a Revenue of US$ 35 Bn by Notching a CAGR of 9.6% by Year 2032-end | Future Market Insights, Inc.

2022-12-07 16:30:16 By : Mr. Frank Chen

The hospitals and clinics segment is expected to hold the largest market share for aesthetic medical devices in the forecast period 2022-2032. the global medical aesthetic devices market is likely to grow significantly due to an increase in various cosmetic procedures, either surgical or nonsurgical, globally

NEWARK, Del, Dec. 05, 2022 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global aesthetic medical devices market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals.

In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages.

Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd.

Request Sample Copy of Report@

Key Takeaways from the Market Study

FMI projects the global aesthetic medical devices market to expand at a 9.6% value CAGR by 2032

The global aesthetic medical devices market is expected to garner a market value of US$ 35,000 Million

North America is expected to grow at a CAGR of 9.5% during the assessment period 2022-2032.

As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 8.7% during the assessment period 2022-2032.

Europe Aesthetic Medical Devices Market is expected to at a CAGR of 9% during the forecast period 2022-2032.

The hospitals and clinics segment is expected to hold the largest market share for aesthetic medical devices in the forecast period 2022-2032.

“During the projection period, the United States market is anticipated to lead the market in North America. This is owing to the excellent healthcare system, technological developments, and strong government financial backing. Furthermore, the growing senior population, peer pressure to seem younger, and the expanding obese or overweight population are fuelling the country's market growth,” says an analyst at FMI

Request Customization @

Market Competition Key players in the aesthetic medical devices market are Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Lumenis Be Ltd., Venus Concept, Candela Corporation, Cutera Inc., Fotona and Asclepion Laser Technologies GmbH.

In December 2021CUTERA, INC. will debut the next generation of truSculpt flex, a quick treatment mode based on Cutera's unique Multi-Directional Stimulation. It achieves the same toning, firming, and strengthening effects in a fraction of the time.

Alma Lasers will debut the new Alma PrimeX platform during a worldwide LIVE launch event in April 2021. Alma PrimeX, the category's top performer, produced unrivalled results in circumference reduction and skin tightening in the belly, waist, thighs, and buttocks.

Candela announced the launch of the Frax Pro system in January 2021. The FDA-approved, non-ablative fractional device is the first to offer dual-depth skin resurfacing with the Frax 1550 and Frax 1940 applicators. The two modalities work on distinct levels of the skin, promoting new collagen formation and displaying smoother, brighter skin.

Future Market Insights, in its new offering, presents an unbiased analysis of the global aesthetic medical devices market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of By Technology {Laser-Based, Electromagnetic Energy-Based, Ultrasound-Based, Cryolipolysis, Suction-Based, and Plasma Energy-Based), Application (Facial Skin Resurfacing, Photorejuvenation, Hair Removal, Fat Reduction and Body Contouring, Skin Tightening, Cellulite Reduction, Feminine Rejuvenation, Tattoos and Pigmentation, Acne and Acne Scars, Vascular Lesions, and Others), and End User (Dermatology and Cosmetic Clinics, Hospitals and Clinics, Medical Spas, and Home Use) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Ask an Analyst @

About the Healthcare Division at Future Market Insights The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

Key Segments Profiled in the Aesthetic Medical Devices Market Industry Survey

Aesthetic Medical Devices Market by Technology:

Aesthetic Medical Devices Market by Application:

Fat Reduction and Body Contouring

Aesthetic Medical Devices Market by End User:

  2.2. Market Definition / Scope / Limitations

Complete TOC with Report Preview:

More Trending Reports by Future Market Research:

Peptide Therapeutics Market Size : The global Peptide Therapeutics Market is currently valued at US$ 34.4 Bn, and is expected to reach US$ 47 Bn by 2025, expanding at an impressive CAGR of 11% over the period of 2022 to 2025.

Dermal Fillers Market Demand : Dermal Fillers Market is projected to exhibit 2.9% CAGR between 2021 and 2031.

Biopharmaceutical Contract Manufacturing Market Value : Global demand for the biopharmaceutical contract manufacturing market is expected to register a CAGR of 10.5% by garnering a market value of US$ 18.7 Billion by 2029.

Pharmaceutical Filtration Market Trends : The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032.

Airway Management Devices Market Forecast : The global Airway Management Devices Market is estimated to expand from a value of US$ 1.45 Bn in 2021, to a value of US$ 1.81 Bn by 2028 end, and growing at a CAGR of 3.2% during the forecast period.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Future Market Insights Inc.   Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA   T: +1-845-579-5705   For Sales Enquiries:

Shares of Bank of America (NYSE: BAC) were down on Tuesday, falling as much as 6% during the trading day. As of 2:45 p.m. ET, Bank of America was down 5.5%, trading at $32.58. The major indexes were all down on Tuesday, led by the Nasdaq Composite, which was down 258 points, or 2.3%, while the Dow Jones Industrial Average was down 498 points, or 1.5%, and the S&P 500 was off 77 points, or 1.9%, as of 2:45 p.m. ET.

Should investors prepare for a winter full of persistent headwinds? Inflation remains high, rising interest rates are putting a squeeze on capital as well as making consumer credit more expensive, and both the China COVID lockdowns and the Russian war in Ukraine continue to crimp global supply chains. But even though the markets are facing serious headwinds, not every stock is going to react by falling. According to the analysts at Wall Street giant Deutsche Bank, two interesting stocks are like

Shares of many of America's largest banks are tumbling again on Tuesday after a period of outperformance that saw Goldman Sachs Group GS claw back practically all of its losses year-to-date.

General Electric, whose spinoff of its health care and energy companies will leave Evendale-based GE Aerospace as the sole company, bought out every single print add in the New York Times for the first time in the newspaper's history.

Even a dour outlook for the broader stock market couldn't outweigh good news for these companies.

Binance CEO CZ is speaking out against SBF after FTX’s collapse and arguing he had nothing to do with his rival’s downfall.

Don’t get fooled into thinking the stock market’s recent positive action has legs. Morgan Stanley’s Chief U.S. Equity Strategist Mike Wilson thinks it’s time to take profits “before the Bear returns in earnest.” Wilson notes that his team’s tactical targets have been met and thinks the recent run-up has run its course. “Bear market rally runs into our original resistance levels--it's time to fade it,” says Wilson. With the “risk-reward of playing for more upside quite poor at this point,” Wilson

The first fast-paced company with serious upside is hydrogen fuel-cell solution provider Plug Power (NASDAQ: PLUG). According to analyst Amit Dayal of H.C. Wainwright, Plug Power can reach $78. For those of you keeping score at home, this would work out to a near-quintupling in the company's share price in 2023.

Shares of major oil stocks, including diversified majors Chevron (NYSE: CVX), ExxonMobil (NYSE: XOM), and pipeline giant Kinder Morgan (NYSE: KMI) all fell on Tuesday, declining 2.4%, 3%, and 2.6%, respectively, as of 2:41 p.m. ET. The entire market was down today, as recession fears appeared to loom over most stocks. A recession of course wouldn't be good for any commodity, oil and gas included.

The FTX-linked trading firm made a number of unorthodox investments in the months leading up to its stunning collapse.

While NIO and Li Auto (LI) hit monthly-record deliveries in November, XPeng (XPEV) sees a sharp fall in deliveries on a yearly basis.

The market rally has erased all the gains from Fed chief Jerome Powell's Nov. 30 speech. Apple and Exxon undercut key levels. Here's what to do now.

Shares of Devon Energy (NYSE: DVN) fell 11.4% in November, according to data provided by S&P Global Market Intelligence. The primary factor weighing on the oil stock was its third-quarter report, where the company unveiled a lower total dividend payment. Devon Energy launched the oil industry's first fixed-plus-variable dividend framework in early 2021.

A broad cross-section of stocks tumbled again on Tuesday as market watchers focused on the Federal Reserve Bank's ongoing battle against inflation. Over the past several days, a couple of strong economic reports have increased concerns about the trajectory of an already overheated economy. With that as a backdrop, shares of Amazon (NASDAQ: AMZN) fell 2%, Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) tumbled 2.4%, and Shopify (NYSE: SHOP) had slumped 4% as of 12:19 p.m. ET.

A strong jobs report these days runs counter to the Fed’s wishes. The line of thought is that if the job market is still too hot, the Fed won’t be keen on loosening its tight monetary policy in the ongoing efforts to tame inflation. And this is a scenario the market is keen to avoid after a series of 75 basis-point hikes this year. But J.P. Morgan Asset Management chief strategist David Kelly thinks the latest numbers flatter to deceive and believes the way the data is reported distorts the real

Recessions aren't fun to live through. But if you're prepared, they don't have to be painful for your portfolio, either.

Blackstone Inc said redemptions from its $50 billion non-traded business development company reached its pre-set limit for the first time but investors were still allowed to cash out on their investments. This is the first time redemption requests had reached the pre-set limit of 5% since Blackstone launched the product in January last year. It also comes after Blackstone announced last Thursday that it would curb withdrawals from its $69 billion unlisted real estate income trust (REIT) following a surge in redemption requests.

(Bloomberg) -- President Joe Biden celebrated Taiwan Semiconductor Manufacturing Co.’s plans to increase its investments in Arizona to $40 billion and construct a second factory, with companies like Apple Inc. eager to source more chips from the US.Most Read from BloombergTrump Companies Are Convicted in NY Criminal Tax Fraud TrialWall Street Goes Risk Off as Bank CEOs Sound Alarm: Markets Wrap‘Huge, Missing and Growing:’ $65 Trillion in Dollar Debt Sparks ConcernEx-Deutsche Bank Trader Builds $

After a punishing 2022, it may be time to bet on bonds backed by the U.S. government, particularly if a recession hits, according to Truist Advisory Services.

The EV stock has been stuck in a range in recent weeks. That isn't going to change for a while, but if it does, the risk is skewed to the downside.